{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:36:34Z","timestamp":1789389394588,"version":"build-2803163510"},"reference-count":142,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1517\/14728222.2014.948420","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T04:56:49Z","timestamp":1412830609000},"page":"1339-1354","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":71,"title":["Placental growth factor in cancer"],"prefix":"10.1517","volume":"18","author":[{"given":"Mieke","family":"Dewerchin","sequence":"first","affiliation":[{"name":"Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB and Department of Oncology, KU Leuven","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carmeliet","sequence":"additional","affiliation":[{"name":"Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB and Department of Oncology, KU Leuven","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.20.9267"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.1.025"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s003359900003"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.22.10705"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.35.22272"},{"key":"e_1_3_2_8_1","first-page":"31","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"Persico MG","year":"1999","unstructured":"Persico MG, Vincenti V, DiPalma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 1999;237:31-40","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.451831"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1247663"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/87904"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.27835"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2524"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.036"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209310110"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03203.x"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011056"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.1.023"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.1.1"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47298-5"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00263.x"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003905"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119069"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.13.7717"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-010-9190-0"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2609"},{"key":"e_1_3_2_27_1","first-page":"265","article-title":"A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism","volume":"1","author":"Tarallo V","year":"2011","unstructured":"Tarallo V, Tudisco L, De Falco S. A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. Am J Cancer Res 2011;1:265-74","journal-title":"Am J Cancer Res"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1977"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2005.16.1422"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.051041"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm884"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08945"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00028-4"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3085"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1034"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.63"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2687"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2009.0170"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10144"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1309629110"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2009.12.001"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2276"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.038"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.039"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.009"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.033"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109029108"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm731"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-20-39"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4092"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0831"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605746"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140917958"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.05.007"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.1"},{"key":"e_1_3_2_58_1","first-page":"241","article-title":"Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-kappaB","volume":"38","author":"Levati L","year":"2011","unstructured":"Levati L, Ruffini F, Muzi A, et al. Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-kappaB. Int J Oncol 2011;38:241-7","journal-title":"Int J Oncol"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0908026106"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.259re1"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018076"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.09.032"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3684"},{"key":"e_1_3_2_65_1","first-page":"2749","article-title":"Placental growth factor is a survival factor for tumor endothelial cells and macrophages","volume":"62","author":"Adini A","year":"2002","unstructured":"Adini A, Kornaga T, Firoozbakht F, et al. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002;62:2749-52","journal-title":"Cancer Res"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-5137fje"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11059"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.014"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2011.315"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6241"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902378"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64255-1"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1278"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.002"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.01.007"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24260"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9381-6"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.2174\/15680096113136660107"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04186"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08261"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08254"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006525"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0119"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24238"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3317"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.10.023"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0461"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283554219"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.112086"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986610791112729"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1355"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2911"},{"key":"e_1_3_2_93_1","first-page":"231","article-title":"Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib","volume":"4","author":"Jitawatanarat P","year":"2013","unstructured":"Jitawatanarat P, Wee W. Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib. J Gastrointest Oncol 2013;4:231-8","journal-title":"J Gastrointest Oncol"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.11.021"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0078"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S39360"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2014.02.001"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.08.007"},{"issue":"8","key":"e_1_3_2_99_1","first-page":"abstract no 137","article-title":"RO5323441, a humanized monoclonal antibody against the placenta growth factor, blocks PlGF-induced VEGFR-1 phosphorylation in vitro and tumor growth in vivo. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC Philadelphia (PA): AACR","volume":"70","author":"Rizzo C","year":"2010","unstructured":"Rizzo C, Yin Xin X, Packman K, et al. RO5323441, a humanized monoclonal antibody against the placenta growth factor, blocks PlGF-induced VEGFR-1 phosphorylation in vitro and tumor growth in vivo. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC Philadelphia (PA): AACR. Cancer Res 2010;70(8 Suppl):abstract no 1370","journal-title":"Cancer Res"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.679655"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.609"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.2092"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.30"},{"key":"e_1_3_2_104_1","first-page":"1992","article-title":"Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy","volume":"7","author":"Harris AL","year":"2001","unstructured":"Harris AL, Reusch P, Barleon B, et al. Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin Cancer Res 2001;7:1992-7","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_105_1","first-page":"1647","article-title":"The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma","volume":"23","author":"Nagaoka S","year":"2010","unstructured":"Nagaoka S, Yoshida T, Akiyoshi J, et al. The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma. Oncol Rep 2010;23:1647-54","journal-title":"Oncol Rep"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.2178"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.05.020"},{"key":"e_1_3_2_108_1","first-page":"239","article-title":"PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance","volume":"6","author":"Escudero-Esparza A","year":"2009","unstructured":"Escudero-Esparza A, Martin TA, Davies ML, et al. PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. Cancer Genomics Proteomics 2009;6:239-46","journal-title":"Cancer Genomics Proteomics"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.050831"},{"key":"e_1_3_2_110_1","first-page":"1437","article-title":"Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?","volume":"59","author":"Gomceli I","year":"2012","unstructured":"Gomceli I, Tez M, Bostanci EB, et al. Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients? Hepatogastroenterology 2012;59:1437-40","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_2_111_1","first-page":"4953","article-title":"Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels","volume":"23","author":"Matsumoto K","year":"2003","unstructured":"Matsumoto K, Suzuki K, Koike H, et al. Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res 2003;23:4953-8","journal-title":"Anticancer Res"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-286"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25492"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.10.005"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1761-9"},{"key":"e_1_3_2_116_1","first-page":"537","article-title":"PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance","volume":"23","author":"Escudero-Esparza A","year":"2010","unstructured":"Escudero-Esparza A, Martin TA, Douglas-Jones A, et al. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncol Rep 2010;23:537-44","journal-title":"Oncol Rep"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.07.022"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-1957-0"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.313"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-3-68"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21335"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2012.04.009"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0223"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-012-0401-6"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.03.017"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cloc.2011.04.003"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.5635"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077117"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.85"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.5416"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1442"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.9908"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3041"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0465"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.798"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.65"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0947"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.11.021"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0271"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1747"},{"key":"e_1_3_2_141_1","first-page":"1569","article-title":"Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines","volume":"11","author":"Viglietto G","year":"1995","unstructured":"Viglietto G, Maglione D, Rambaldi M, et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995;11:1569-79","journal-title":"Oncogene"},{"key":"e_1_3_2_142_1","first-page":"607","article-title":"Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors","volume":"77","author":"Sowter HM","year":"1997","unstructured":"Sowter HM, Corps AN, Evans AL, et al. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest 1997;77:607-14","journal-title":"Lab Invest"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-06-0141"},{"key":"e_1_3_2_144_1","first-page":"763","article-title":"Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas","volume":"148","author":"Hatva E","year":"1996","unstructured":"Hatva E, Bohling T, Jaaskelainen J, et al. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996;148:763-75","journal-title":"Am J Pathol"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14728222.2014.948420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:12:47Z","timestamp":1772745167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14728222.2014.948420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":142,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1517\/14728222.2014.948420"],"URL":"https:\/\/doi.org\/10.1517\/14728222.2014.948420","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}